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Abstract Juvenile myoclonic epilepsy (JME) is a genet-
ically determined common subtype of idiopathic general-
ized epilepsy. Linkage of JME to the chromosomal region
6p21.3 has been reported. An association has been previ-
ously observed between JME and the positional candidate,
6p21.3 linked, BRD2. Another candidate in this region is
the TAP-1 gene encoding the Transporter Associated with
Antigen Processing. The aim of the present study is to
determine whether these two genes modulate the vulnera-
bility to JME. While no difference was observed in the
allele and genotype frequencies of BRD2 between JME and
controls, an association was found between a TAP-1
haplotype and JME, suggesting that this gene may be
another 6p21.3 linked vulnerability factor to JME.
Keywords Juvenile myoclonic epilepsy  BRD2 
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Introduction
Juvenile myoclonic epilepsy (JME) is the most common
form of idiopathic generalized epilepsy (IGE) that account
for about 5–10% of all types of epilepsies [1]. It starts in
adolescence and is mainly characterized by isolated myo-
clonic jerks on awakening that usually begin during ado-
lescence. It is also highly drug-dependent, since 90%
recurrence is reported after interruption of pharmacological
treatment [2, 3].
Family and twin studies have provided strong evidence
for a genetic contribution to JME [4]. In rare Mendelian
JME, 15 loci have been suggested by linkage analysis [5].
Private mutations in two ion channel genes (a1-subunit of
the GABAA receptor and chloride channel 2) and one non-
ion channel (myoclonin/EFHC1) have been identified as
putative JME genes [review in 5]. However, the genetics of
JME is complex and involves probably the interaction of
several genes with minor effect and environmental factors
[4].
A first putative locus termed EJM1 (OMIM 254770), is
on the human leukocyte antigen (HLA) region of chro-
mosome 6p, and was significantly associated with HLA-
DR13 [6]. However, several association studies suggested
that other JME loci might be present on chromosome 6p
(review in [5]). In 2003, Pal et al. [7] reported a linkage
disequilibrium between single nucleotide polymorphisms
(SNPs) and one haplotype within the BRD2 (RING3) gene,
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in chromosome 6p21.3, and JME. Four other studies, with
mixed results, of IGEs or photoparoxysmal response, using
BRD2 polymorphisms, have been published to date [8–11].
Because of this inconsistencies and strong linkage dis-
equilibrium within the 6p21.3 region, between HLA-DQ
and HLA-DP, it is important to further explore this can-
didate gene, as well as other 6p21.3 positional candidates.
Transporter Associated with Antigen Processing 1 (TAP-1)
is one of these candidate genes. The TAP-1 (also known as
RING4 or PSF1, OMIM 170260) gene belongs to a family
of membrane transporters that possess an ATP binding
cassette and 6–8 transmembrane domains [12]. The ATP-
binding cassette transporter TAP translocates peptides from
the cytosol to awaiting major histocompatibility complex
(MHC) class I molecules in the endoplasmic reticulum.
TAP is made up of the TAP1 and TAP2 (OMIM 170261)
polypeptides.
TAP-1 gene comprises 11 exons and it is known to be
polymorphic with several polymorphisms identified in
different populations. To date, 13 nucleotide sequence
variants have been described in TAP-1 coding sequences
[13–18]. Interestingly, Jackson and Capra [19] have
reported an association between a polymorphism at the
TAP-1 locus and insulin-dependent diabetes mellitus, a
disease that seems to be associated with a higher risk for
epilepsy [20].
The aim of the present study is to further explore BRD2
SNPs and to determine whether two TAP-1 functional
polymorphisms—one located in exon 4, Ile333Val, and one
in exon 10, Asp637Gly [12]—modulate the vulnerability to
JME.
Methods
Subjects
The gene and allele frequencies gene were determined in a
French sample comprising 154 healthy subjects and 159
unrelated patients with JME. Patients were 98 females and
61 men. They have a mean age of (28.3 ± 7.5 years) and
were recruited as described previously [21] according to
the classification of the International League Against Epi-
lepsy [22]. Photoparoxysmal response or photosensitive
epilepsy was established in 47 patients. The other 112 were
tested and were negative.
Control subjects were 48 women and 106 men with a
mean age of (37.2 ± 9.6 years). They were unrelated
healthy blood donors. Anyone of them had evidence of any
personal or family history of epilepsy. Control subjects and
patients were selected from the same West European
Caucasian, French-speaking population [21].
Molecular methods
BRD2 genotyping
We investigated three BRD2 SNPs: one, rs3918149, in the
promoter region, that displays the highest odd ratio in the
study by Pal et al. [7] and two, rs516535 and rs206781, in
the 30 region, that showed the strongest association in the
study of photoparoxysmal response [9]. The later were also
significantly associated with JME in the study by Pal et al.
[7] and were tested in [10]. Genotyping was carried out
using ABI Taqman technology (details of Taqman probes
are available on request).
Genotyping of the TAP-1 dimorphism
The polymorphisms within TAP-1 were analyzed using
Polymerase Chain Reaction and Single-Strand Conformation
Polymorphism (SSCP) analyses. Amplification reactions for
the SSCP analyses for both polymorphisms contained 1 lg of
DNA, 200 lM of each dNTP, 150 lM MgCl2, 0.2 lM of
primers, 2 Units of Taq polymerase and 19 Taq buffer, in a
total volume of 48 ll. Primers were: TAP-1(Ile333Val) (F)
CTGAGTGATTCTCTGAGTGAG and (R) CATTTTCCC
ACCTTCTTGGG; TAP-1 (Asp637Gly): (F) TGTGGCTA
TACCGTTCTCATC and (R) GGATAAGTACACACGGT
TTCC. PCR cycling conditions included 3 minutes initial
denaturizing step at 94C, followed by 29 cycles of 30 s at
92C, 30 s at appropriate annealing temperature—58C for
both Ile333Val and Asp637Gly—and 30 s at 72C for
extension step. Amplification products are resolved on TBE
19 4–6% polyacrylamide denaturing gels, which are run for
3 h at 300 V. Fragments’ sizes were 161 bp for Ile333Val and
133 bp for Asp637Gly.
Statistical analysis
Two-tailed Chi-square or Fisher’s exact tests were used to
compare allelic and genotypic distributions between the
JME and control groups. Linkage disequilibrium and hap-
lotypes frequencies were estimated using the PHASE and
HAPLOVIEW programs [23, 24]. Since we compared
genotypic and allelic distributions of five polymorphic
markers between JME patients and controls, a correction
for multiple testing was required. For a Bonferroni cor-
rection on the p values for interaction, we therefore used
p = 0.05/5 = 0.01 as a threshold for significance.
Results
Genotype and alleles frequencies of all BRD2 and TAP-1
markers in the different groups were in Hardy–Weinberg
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equilibrium. We found no significant differences between
the allelic (Table 1) and genotyping (data not shown) dis-
tributions of all three BRD2 SNPs between JME and con-
trol groups. No difference was also observed in the sub-
sample of patient with photoparoxysmal response or pho-
tosensitive epilepsy (data not shown). No gender effect was
found.
Similarly, no difference was observed between the allele
distributions of both TAP-1 SNPs (Table 1). As previously
reported [12], we found incomplete linkage disequilibrium
between the two functional TAP-1 SNPs, the haplotypes
333Ile-637Asp and 333Val-637Gly being more frequent
than calculated in both controls and patients. Interestingly,
the two rare haplotypes, 333Val-637Asp and 333Ile-
637Gly, are more frequent in JME patients than in controls:
2.61, 95%CI (1.27–5.33), uncorrected p = 0.007 and 2.30,
95%CI (1.11–4.77), uncorrected p = 0.02, respectively)
(Table 1). After correction for multiple testing the associ-
ation with 333Val-637Asp remains significant (pc = 0.04).
Discussion
This study was first designed to attempt replication of the
association between a promoter BRD2 SNP, rs3918149,
and JME observed in a family-based association study [7]
and replicated in small samples from British (34 JME and
256 controls) and Irish (57 JME, 227) origins [11]. Our
negative result is in line with those reported with the same
variant in other populations (German, Australian, and
Indian) [11]. We also did not replicate the association
found between two 30BRD2 SNPs and photoparoxysmal
response [9].
Power to detect association at the level of a = 0.01 in
this study was around 0.80 if genotype relative risks were 6
as reported by Pal et al. [7]. But the power falls with lower
genotype relative risks (less than 0.50 with relative risks
lower than 2.0). Therefore, our study may be underpowered
in these figures. However, it must be emphasized that the
two positive results were observed in small samples [11],
while the negative ones were found in the largest ones ([11]
and the present study).
We considered the hypothesis that these inconsistencies
are because the causal variant lies outside BRD2, since
linkage disequilibrium is high across the region containing
this gene. Several other coding regions have been unsuc-
cessfully sequenced in the BRD2 region by Pal et al. [11].
We therefore decided to test a positional candidate that has
not been considered in previous studies, TAP-1. A pre-
liminary, unpublished, study performed in a sample of
Tunisian IGE patients suggested an association with this
gene (S. Layouni, MSc thesis). The present results suggest
that two TAP-1 haplotypes are susceptibility factors to
JME. This association now requires further replication in
carefully phenotyped and closely matched populations.
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